je.st
news
Home
› DelMar Pharmaceuticals Presents Promising VAL-083 Interim Data from GBM Clinical Trial at ASCO
DelMar Pharmaceuticals Presents Promising VAL-083 Interim Data from GBM Clinical Trial at ASCO
2014-05-31 15:14:22| Logistics - Topix.net
DelMar Pharmaceuticals, Inc. announced the presentation of interim clinical data from the company's ongoing clinical trial with VAL-083 in refractory glioblastoma multiforme during the Central Nervous System Tumor Session at the 50 Annual Meeting of the American Society of Clinical Oncology , which is being held at the McCormick Place Convention ... (more)
Tags: data
trial
presents
clinical
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|